Slide Presentation: AMP v Myriad, Gene Patents
A Carr & Ferrell attorney gave a guest presentation on AMP v. Myriad at Professor Larry Lasky’s Entrepreneurship in Biotechnology class at UC Berkeley’s Haas School of Business. The presentation included an overview of the case, and explored how this ruling could impact the future of gene patents.
Last spring, a federal district court sent shockwaves through the life science and legal communities when it struck down several of Myriad Genetics’ patent claims regarding genes linked to ovarian and breast cancer. In a move that could shape the future of gene patenting if upheld, the court ruled that DNA sequences are not, in and of themselves, patentable subject matter.
Myriad has appealed that decision to the U.S. Court of Appeals for the Federal Circuit, which will hear oral arguments in April 2011.
Inventors attending CES may bring notes and a drawing of their invention to booth 70555 to be eligible for a free patent application.
The firm’s new website will feature an enhanced resource center, responsive design, and a clean, modern look.
Members of the Security and Surveillance panel will explore the issues facing brand owners in the wake of recent data breaches at large trusted retailers, and in the light of disturbing revelations about government surveillance and back-door access to customer data.
The multiple patents for Wide Area Networks continue to expand Silver Peak's IP portfolio and their commitment to innovation.